AMISTAD


AMISTAD

Acute Myocardial Infarction Study of Adenosine. A clinical trial to determine the efficacy of IV adenosine with either streptokinase or tPA in limiting the size of acute MIs. 
Conclusion
33% decrease in infarct size seen with adenosine and 67% if the infarction was anterior in location; clinical outcomes with adenosine were slightly worse than with placebo.

AMISTAD

Cardiology A clinical trial–Acute Myocardial Infarction Study of Adenosine to determine the efficacy of IV adenosine in combination with either streptokinase or tPA in limiting the size of AMIs See Acute myocardial infarction.